Mismatch repair-proficient

Clinical trials for Mismatch repair-proficient explained in plain language.

Never miss a new study

Get alerted when new Mismatch repair-proficient trials appear

Sign up with your email to follow new studies for Mismatch repair-proficient, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Terminated 1

Promising cancer combo study halted early – only 4 black women enrolled

Disease control Stopped early

This study aimed to see if a combination of two drugs, lenvatinib and pembrolizumab, could shrink tumors in Black women with a certain type of recurrent endometrial cancer. Only 4 participants were enrolled before the study was stopped early. The goal was to measure how many pati…

Matched conditions: MISMATCH REPAIR-PROFICIENT

Phase 2 • Sponsor: Virginia Commonwealth University • Aim: Disease control

Last updated Jun 27, 2026 07:52 UTC

Mismatch repair-proficient

Get alerted when new Mismatch repair-proficient trials appear

Promising cancer combo study halted early – only 4 black women enrolled